Cargando…

The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke

OBJECTIVES: To assess and explore over 1 year poststroke (1) the societal costs, (2) changes in costs and quality of life (QoL) and (3) the relation between costs and QoL. DESIGN: The current study is a burden of disease study focusing on the cost-of-illness (in Euros) and QoL (in utilities) after s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Eeden, M, van Heugten, C, van Mastrigt, G A P G, van Mierlo, M, Visser-Meily, J M A, Evers, S M A A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663410/ https://www.ncbi.nlm.nih.gov/pubmed/26614618 http://dx.doi.org/10.1136/bmjopen-2015-008220

Ejemplares similares

Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort
por: van Mastrigt, Ghislaine, et al.
Publicado: (2022)

The economic impact of mental healthcare consumption before and after stroke in a cohort of stroke patients in the Netherlands: a record linkage study
por: van Eeden, M., et al.
Publicado: (2016)

The economic impact of stroke in The Netherlands: the €-restore4stroke study
por: van Eeden, Mitchel, et al.
Publicado: (2012)

A trial-based economic evaluation of the Restore4Stroke self-management intervention compared to an education-based intervention for stroke patients and their partners
por: van Mastrigt, Ghislaine A. P. G., et al.
Publicado: (2020)

An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms
por: van Eeden, M., et al.
Publicado: (2015)

Cerebrospinal fluid leakage costs after craniotomy and health economic assessment of incidence reduction from a hospital perspective in the Netherlands
por: van Lieshout, Chris, et al.
Publicado: (2021)

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands
por: Van der Linden, N., et al.
Publicado: (2020)

Screening and follow-up care for cognitive and emotional problems after transient ischaemic attack and ischaemic stroke: a national, cross-sectional, online survey among neurologists in the Netherlands
por: Slenders, Jos, et al.
Publicado: (2021)

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017
por: Huang, Shao-Yi, et al.
Publicado: (2020)

Economic evaluation of nurse-led stroke aftercare addressing long-term psychosocial outcome: a comparison to care-as-usual
por: Verberne, Daan P J, et al.
Publicado: (2021)

Identifying costs in health professions education: a scoping review protocol
por: Yaros, Jennifer, et al.
Publicado: (2023)

Poststroke Fatigue: Who Is at Risk for an Increase in Fatigue?
por: van Eijsden, Hanna Maria, et al.
Publicado: (2012)

Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
por: de Jong, Lisa A, et al.
Publicado: (2020)

Burden, anxiety and depressive symptoms in partners – course and predictors during the first two years after stroke
por: Cox, Vincent C.M., et al.
Publicado: (2022)

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
por: Hoogendoorn, Martine, et al.
Publicado: (2021)

The burden of colorectal cancer survivors in the Netherlands: costs, utilities, and associated patient characteristics
por: Mulder, Frederike E. C. M., et al.
Publicado: (2021)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Overweight and obesity on the island of Ireland: an estimation of costs
por: Dee, Anne, et al.
Publicado: (2015)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

Is reduction of routine radiograph use in patients with distal radius fractures cost effective? Analysis of data from the multicentre, randomised controlled WARRIOR trial
por: van Gerven, Pieter, et al.
Publicado: (2020)

Social cognition impairments are associated with behavioural changes in the long term after stroke
por: Nijsse, Britta, et al.
Publicado: (2019)

Economic burden of managing oral cancer patients in Sri Lanka: a cross-sectional hospital -based costing study
por: Amarasinghe, Hemantha, et al.
Publicado: (2019)

Course of Social Participation in the First 2 Years After Stroke and Its Associations With Demographic and Stroke-Related Factors
por: Verberne, Daan P. J., et al.
Publicado: (2018)

A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population
por: Neyt, Mattias, et al.
Publicado: (2012)

Cost comparison of orthopaedic fracture pathways using discrete event simulation in a Glasgow hospital
por: Anderson, Gillian H, et al.
Publicado: (2017)

Evidence-based recommendations for economic evaluations in spine surgery: study protocol for a Delphi consensus
por: Droeghaag, Ruud, et al.
Publicado: (2021)

Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment
por: Droeghaag, Ruud, et al.
Publicado: (2023)

Advocating uniformity in spine surgery: a practical disease-specific guideline for trial-based economic evaluations
por: Schuermans, Valérie N E, et al.
Publicado: (2023)

Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective
por: Ni, Weiyi, et al.
Publicado: (2020)

Cost-effectiveness of stroke care in Aboriginal and non-Aboriginal patients: an observational cohort study in the Northern Territory of Australia
por: Zhao, Yuejen, et al.
Publicado: (2017)

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
por: Marvel, Jessica, et al.
Publicado: (2019)

Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
por: Kohli-Lynch, Ciaran N, et al.
Publicado: (2022)

Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis
por: Oostdijk, Evelien A N, et al.
Publicado: (2013)

Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial
por: Boere, Tjarda M, et al.
Publicado: (2022)

Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore
por: Cher, Boon Piang, et al.
Publicado: (2017)

Cost of oropharyngeal dysphagia after stroke: protocol for a systematic review
por: Marin, Sergio, et al.
Publicado: (2018)

Screening and patient-tailored care for emotional and cognitive problems compared to care as usual in patients discharged home after ischemic stroke (ECO-stroke): a protocol for a multicenter, patient-blinded, cluster randomized controlled trial
por: Slenders, J. P. L., et al.
Publicado: (2020)

Exploring the wider societal impacts of sexual health issues and interventions to build a framework for research and policy: a qualitative study based on in-depth semi-structured interviews with experts in OECD member countries
por: Schnitzler, Lena, et al.
Publicado: (2023)

Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis
por: Lee, Peter, et al.
Publicado: (2023)

Cost-effectiveness of Early Surgery versus Conservative Treatment with Optional Delayed Meniscectomy for Patients over 45 years with non-obstructive meniscal tears (ESCAPE study): protocol of a randomised controlled trial
por: van de Graaf, Victor A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p81q17445maq62ifsq2vb1ta6d